Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Edition
European
US
Dermatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Tralokinumab – Updates in Atopic Dermatitis
8
Mins
January 2026
A summary of new data on tralokinumab in atopic dermatitis, presented at conferences/symposia held between September and October 2024.
Read more
9
Mins
30 Oct 2018
IL-23 Inhibition in Psoriasis: Changing the Present, Shaping the Future
This symposium took place at the 27th European Academy of Dermatology and Venereology (EADV) Congress. The session examined the latest data for…
9
Mins
30 Oct 2018
From Evolution to Revolution: IL-23 in the Treatment of Psoriasis Patients
This symposium, which took place during the 2018 meeting of the European Academy of Dermatology and Venereology (EADV) in Paris, France, provided…
10
Mins
30 Oct 2018
Emerging Insights in the Treatment of Psoriasis and Psoriatic Arthritis
Guselkumab is a monoclonal antibody targeting IL-23 that is approved for the treatment of patients with moderate-to-severe plaque psoriasis. Two of…
9
Mins
30 Oct 2018
Efficacy, Sustainability, and Patient-Reported Outcomes of Guselkumab to Treat Plaque Psoriasis in the Post-Approval Setting
Plaque psoriasis is an autoimmune condition characterised by the development of red, dry, scaly skin lesions that cause irritation and pain for patients…
8
Mins
9 Aug 2018
The Changing Landscape of Psoriasis: New Horizons for Oral Therapies
Prof Boehncke opened the symposium and highlighted the changing landscape of psoriasis management. On behalf of Prof Mrowietz, who was unable to attend…
6
Mins
9 Aug 2018
Psoriasis: From Gene to Clinic
Substantial developments over the last decade have advanced our knowledge and understanding of psoriasis, from both a basic scientific and clinical…
10
Mins
21 Jun 2018
A Review of the European Society for Photodynamic Therapy (Euro-PDT) Annual Congress 2018
This article reviews new data presented at the recent European Society for Photodynamic Therapy (Euro-PDT) Annual Congress 2018. The role of topical…
8
Mins
7 Jun 2018
Treating Psoriasis: What Is New About Fumaric Acid Esters?
This publication covers the first session of Almirall’s 11th Skin Academy meeting in Barcelona, Spain. This year, the meeting theme was ‘The Science of…
Loading posts...
« Previous
1
…
7
8
9
10
11
12
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View